Health Canada’s chief medical advisor Supriya Sharma discussed the experimental COVID-19 pill molnupiravir, which drugmaker Merck says reduces hospitalizations and deaths by half in people recently infected with the coronavirus. Sharma told reporters that Health Canada is working on the review process with international partners after receiving a submission from Merck in August.
Canada
Health Canada looking into experimental COVID-19 pill molnupiravir, Sharma says
More Videos
-
NHL worried about Milan’s unfinished Olympic hockey arena
-
Liberals target pornographic deepfakes in Criminal Code overhaul
-
NHL players would skip Winter Olympics in Milan if ice rink unsafe, say officials
-
Bank of Canada holds interest rates steady as Trump tariffs remain threat to economy
-
The Morning Show: December 10
-
Health Matters: Alberta government invokes notwithstanding clause for 4th time
You are viewing an Accelerated Mobile Webpage.
View Original Article